News

In a new study of 18,000 Medicare beneficiaries with venous thromboembolism, apixaban is associated with fewer complications and more days at home. 

Study quantifies how often people with cognitive decline develop conditions that could require anticoagulant or thrombolytic therapy

Behavioral science-based reminders built into electronic health records can help primary care doctors safely stop or taper potentially harmful medications.

Nationwide study finds lower risk of death and rehospitalization among older adults treated with trazodone after hospital admission.

Anticoagulant use is associated with a clear overall benefit for patients.

SGLT-2 inhibitors like Jardiance and GLP-1 drugs like Ozempic are associated with slower frailty progression in older adults with type 2 diabetes.

National analysis shows long-term use of anticoagulants after an unprovoked blood clot offers major health benefits, despite increase in bleeding risk.

Medicare data may miss the majority of opioid use after hospital discharge in skilled nursing facilities, raising concerns for patient safety and care. 

Prolonged benzodiazepine use puts older adults at risk of falls, cognitive decline, and dependence. 

Continued prevalence of persistent delirium warrants further delirium management efforts.